ArticleNaunyn-Schmiedeberg's archives of pharmacology2021

Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway.

Sutthiwan Janthamala et al.PubMed ↗Publisher ↗

No numbers read from the abstract.